ArticleRheumatology advances in practice2020

One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology.

Wieland D Müskens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.